title: [Current recommendation for asthma treatment].
abstract: Asthma is a chronic inflammatory disease, characterized chronic inflammation of respiratory tract, reversible bronchial obturation and non-specific bronchial hyperresponsiveness. Typical symptoms of asthma are cough, wheezing and dyspnea. Diagnosis should be based on positive reversibility test with beta2-agonist. In the management of asthma patient education, allergen avoidance and anti-inflammatory treatment should be always implemented. Recently fast and long acting beta2-agonist was introduced with great success. Combination treatment with long acting beta2-agonists and topical glucocorticosteroids for patients with moderate and severe chronic asthma is recommended. We can also consider antileukotrienes and long acting theophylline as an option in patients not fully controlled by inhaled steroids. Patient with asthma should be always examined closely for chronic rhinitis and treated accordingly with antihistaminic drugs. Atopic asthma can be also treated with immunotherapy. With new drugs for asthma we can achieve full control of disease symptoms without unwanted side effects.
authors.affiliation: Klinika Pneumonologii i Alergologii Instytutu Medycyny Wewnetrznej Uniwersytetu Medycznego w Lodzi. pkuna@bg.p.lodz.pl
authors.forename: Piotr
authors.initials: P
authors.lastname: Kuna
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy; D013806:Theophylline / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents; D006634:Histamine H1 Antagonists; D020024:Leukotriene Antagonists; D013806:Theophylline